Peter Kohler, MD
Medical Oncology · Traverse City, MINPI 1477520872
Payments from drug & device makers
Across 21 payments — averaging $5209.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$99K
- Pfizer$10K
- Gilead$12
- E.r. Squibb & Sons, L.L.C.$11
What the payments were for
- Education$41100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 18 | $99,378 |
| Pfizer | 1 | $10,000 |
| Gilead | 1 | $12 |
| E.r. Squibb & Sons, L.L.C. | 1 | $11 |
How this compares
$109,401 in reported general payments places this provider in the 55th percentile of 170 medical oncology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Abiraterone Acetate | 219 | $379,591 |
| XtandiEnzalutamide | 26 | $373,851 |
| CabometyxCabozantinib S-Malate | 14 | $364,426 |
| LynparzaOlaparib | 11 | $190,084 |
| OrgovyxRelugolix | 22 | $57,447 |
| Anastrozole | 296 | $10,551 |
| Tamoxifen Citrate | 66 | $2,538 |
| Prednisone | 129 | $1,970 |
| Prochlorperazine Maleate | 51 | $1,023 |
| Dexamethasone | 46 | $380 |
| Levothyroxine Sodium | 37 | $356 |
| Ondansetron Hcl | 58 | $270 |
| Letrozole | 20 | $263 |
| Oxybutynin Chloride | 24 | $234 |
| Ondansetron OdtOndansetron | 20 | $217 |
Paid to pharmacies, not to this prescriber.
Other medical oncology in Traverse City
- Patricia Lo RussoDetroit$24.6M
- Manish SharmaGrand Rapids$19M
- Moshe TalpazAnn Arbor$13.7M
- Shirish GadgeelDetroit$11M
- Zachery ReichertAnn Arbor$10.6M
- Ammar SukariDetroit$8.4M
- Paul SwiecickiAnn Arbor$7.6M
- Rashmi ChughAnn Arbor$7M
- John KraussAnn Arbor$6.2M
- Emerson LimGrand Rapids$6.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.